What is SRTA's other clinical — revenue?

SRTA (SRTA) reported other clinical — revenue of $9.95M in Q1 2026.

What does other clinical — revenue mean?

This metric represents the total revenue generated from the company's 'Other Clinical' business segment, which encompasses specialized medical products or services outside of the primary core offerings. It serves as a key indicator of the company's ability to diversify its clinical portfolio and capture value from niche or emerging medical markets. Tracking this revenue stream helps investors assess the contribution of secondary clinical activities to the overall top-line growth and business diversification strategy.

SRTA SRTA Other Clinical — Revenue

Other product segments

Transplant Clinical

$9.84M—

Similar metrics at other companies

MMSClinical Services — Revenue

$530.81M+5.3%

TOIClinical trials & other — Other Operating Income

$813K-54.2%

VIROther revenue — Total revenues

$0-100%

TOIClinical trials & other — Total operating revenue

$813K-60.2%

MEDPOther — Total Revenue

$93.32M-2.6%

SLPClinical Operations — Revenue

$415K-53.6%

Other financials

Income statement

See full

Revenue$67.4M+87.4%

Gross profit$14.1M+100%

Operating income-$3.0M+47.7%

Net income$2.2M+162%

EPS (diluted)$0.03+175%

Balance sheet

See full

Cash & equivalents$59.0M+65.3%

Total debt$4.5M-50.7%

Total equity$285.7M+30.0%

Total assets$327.6M+30.8%

Cash flow

See full

Operating cash flow$3.9M+1,679%

CapEx$5.2M+98.1%

Free cash flow-$1.3M+54.8%

Valuation

See full

Market cap$463.78M+24.0%

Enterprise value$409.26M—

P/E8.9×—

P/S1.8×—

Profitability

See full

Gross margin21.7%+1.3pp

Operating margin-7.8%-2.8pp

Net margin21%+13.6pp

FCF margin-22.4%+1,712pp

Returns & leverage

See full

Return on equity15.6%+10.0pp

Debt / equity0×0.0×

Current ratio5.9×-1.0×

Where this comes from

Reported directly by SRTA in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: SRTA’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about SRTA's other clinical — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SRTA's other clinical — revenue?: SRTA (SRTA) reported other clinical — revenue of $9.95M in Q1 2026.
What does other clinical — revenue mean?: This metric represents the total revenue generated from the company's 'Other Clinical' business segment, which encompasses specialized medical products or services outside of the primary core offerings. It serves as a key indicator of the company's ability to diversify its clinical portfolio and capture value from niche or emerging medical markets. Tracking this revenue stream helps investors assess the contribution of secondary clinical activities to the overall top-line growth and business diversification strategy.